[3H]MRS 1754, a selective antagonist radioligand for A2B adenosine receptors
- 19 March 2001
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 61 (6) , 657-663
- https://doi.org/10.1016/s0006-2952(01)00531-7
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Anilide Derivatives of an 8-Phenylxanthine Carboxylic Congener Are Highly Potent and Selective Antagonists at Human A2B Adenosine ReceptorsJournal of Medicinal Chemistry, 2000
- Adenosine Receptor Activation Induces Vascular Endothelial Growth Factor in Human Retinal Endothelial CellsCirculation Research, 1999
- Adenosine Receptor Ligands: Potential as Therapeutic Agents in Asthma and COPDPulmonary Pharmacology & Therapeutics, 1999
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS 15943) Having High Potency at the Human A2Band A3Receptor SubtypesJournal of Medicinal Chemistry, 1998
- A Functional Screening of Adenosine Analogues at the Adenosine A2BReceptor: A Search for Potent AgonistsNucleosides and Nucleotides, 1998
- Adenosine A2B receptors: a novel therapeutic target in asthma?Trends in Pharmacological Sciences, 1998
- The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A2a selective adenosine receptor antagonistBritish Journal of Pharmacology, 1995
- Stimulation by Alkylxanthines of Chloride Efflux in CFPAC-1 Cells Does Not Involve A1 Adenosine ReceptorsBiochemistry, 1995
- Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblastsBiochemical Pharmacology, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973